Gilead Sciences Inc (GILD)
108.41
-0.70
(-0.64%)
USD |
NASDAQ |
May 21, 11:35
Gilead Sciences Total Long Term Debt (Quarterly): 24.95B for March 31, 2025
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Amgen Inc | 57.38B |
| Johnson & Johnson | 52.25B |
| Eli Lilly and Co | 38.52B |
| Vertex Pharmaceuticals Inc | 0.00 |
| Moderna Inc | 0.00 |